Literature DB >> 33778731

High Accuracy of PSMA PET in Initial Staging of High-Risk Prostate Cancer.

Joseph Waller, Robert Flavell, Courtney Lawhn Heath.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33778731      PMCID: PMC7983724          DOI: 10.1148/rycan.2020204025

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN: 2638-616X


× No keyword cloud information.
  1 in total

1.  Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

Authors:  Michael S Hofman; Nathan Lawrentschuk; Roslyn J Francis; Colin Tang; Ian Vela; Paul Thomas; Natalie Rutherford; Jarad M Martin; Mark Frydenberg; Ramdave Shakher; Lih-Ming Wong; Kim Taubman; Sze Ting Lee; Edward Hsiao; Paul Roach; Michelle Nottage; Ian Kirkwood; Dickon Hayne; Emma Link; Petra Marusic; Anetta Matera; Alan Herschtal; Amir Iravani; Rodney J Hicks; Scott Williams; Declan G Murphy
Journal:  Lancet       Date:  2020-03-22       Impact factor: 79.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.